Leadership Team

About

The leadership team at Lyell Immunopharma has a history of experience in the US sales and marketing of HER2+ Breast Cancer Portfolio, Global Regulatory Operations Leader, Vice President at Roche/Genentech, and Project Team Leader at Genentech Inc. They also have experience in Exec. Director, Project Leadership & Portfolio Mgmt at Jazz Pharmaceuticals, Founding Member at Chief, Global HR Director, Product Development, Clinical Operations at Genentech, VP/Director, Talent Operations at DigitasLBi, Founder and CEO at Station X, SVP, Chief Genomics Officer at Incyte, Founder & President at Prospect Genomics, VP Research Genomics, CSO Incyte Genetics at Incyte Pharmaceuticals, Board Observer at Outpace Bio, SVP, Global Head of Biologics Operations at AstraZeneca, Vice President Manufacturing at Amgen, Sr. Manager Mfg at ICOS, Vice President at Juno Therapeutics, Inc., Medical Director at Seattle Genetics, Assistant Professor at University of Washington, and Pediatric Oncologist at Seattle Children's. They also have a variety of education histories including Columbia Business School International Business, London Business School Economics and German, Boston College Human Dev Psychology, University of Cape Town Medical Biochemistry, Rhodes University Pharmacology, University of Washington Microbiology General, and University of Washington Cancer Biology.